This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.
To evaluate the safety and efficacy of a novel LASIK technique
This prospective, consecutive eye study included 60 eyes of 30 patients: each eye was treated with the NT that combined automated calculations from a novel, single diagnostic device and software calculated treatment refraction. The 3-month peri-operative visual performance and refractive data were evaluated.
Multidiscipline-guided customized NT appears safe and very effective in myopic LASIK, while using a single diagnostic device.